Kier Group PLC
5 March 2001
Scotland's first PFI hospital handed over
Kier Group has reached a significant stage with its major PFI project in
Scotland - three months early.
On Wednesday (28 Feb), HDGH, a joint Kier Group/Innisfree company, handed over
Scotland's first major PFI hospital to Lanarkshire Acute Hospitals NHS Trust -
three months ahead of schedule.
The new hospital, which has 364 inpatient beds and 52 day beds, is in East
Kilbride and was completed under a £67.5m design & build contract by Kier
Build, the major projects arm of the Kier Group, and is now being made ready
to admit its first patients later this month. This is the first PFI hospital
to open in Scotland.
Kier Group chairman Colin Busby commented: 'When the concession to design
build and finance the hospital was awarded in April 1998, we saw this as our
chance to show how effective the PFI route is. The quality of the finished
building speaks for itself and is a credit to all involved with its delivery -
three months ahead of schedule. We are proud to have been chosen to deliver
this new facility for the people of East Kilbride and to have demonstrated how
successful the PFI delivery route can be.'
The concession, which will also operate and manage non-clinical support
services, has a projected value of £644m over 30 years. Kier Group plc owns
50% of the concession, investing £4.2m in equity and subordinated debt.
5.3.01
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.